Citation Impact
Citing Papers
Global Cancer Incidence and Mortality Rates and Trends—An Update
2015 Standout
Cancer Prevention: From 1727 to Milestones of the Past 100 Years
2009
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo
2006
Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism
2006
Cancer statistics, 2022
2022 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I
2016 Standout
Cancer statistics, 2023
2023 Standout
Clinical Efficacy, Safety and Tolerability of Collagenase Clostridium Histolyticum for the Treatment of Peyronie Disease in 2 Large Double-Blind, Randomized, Placebo Controlled Phase 3 Studies
2013 Standout
Cancer statistics, 2024
2024 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Cancer statistics, 2018
2018 Standout
Removal of urinary catheter on postoperative day 3 or 4 after radical retropubic prostatectomy
2003
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
A view on drug resistance in cancer
2019 StandoutNature
The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics
2008 Standout
Urinary catheter policies for long-term bladder drainage
2005
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Gum Arabic as a Phytochemical Construct for the Stabilization of Gold Nanoparticles: In Vivo Pharmacokinetics and X‐ray‐Contrast‐Imaging Studies
2007 Standout
Nanoparticles in Medicine: Therapeutic Applications and Developments
2007 Standout
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
2013 Standout
Systematic Evidence-Based Analysis of Plaque Injection Therapy for Peyronie's Disease
2006
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
The Risks and Benefits of 5α-Reductase Inhibitors for Prostate-Cancer Prevention
2011
Biodegradable luminescent porous silicon nanoparticles for in vivo applications
2009 Standout
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Peyronie's Disease
2007
Sexual Dysfunction in Women With Type 1 Diabetes
2009
Efficiency of oocyte cryopreservation: a meta-analysis
2006
Epidemiology of Prostate Cancer
2019 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Ejaculatory frequency and the risk of aggressive prostate cancer: Findings from a case-control study
2017
Assessment of erectile dysfunction in diabetic patients
2008
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
MANAGEMENT OF PROSTHESIS INFECTIONS IN UROLOGIC SURGERY
1999
Risk Factors for Emotional and Relationship Problems in Peyronie's Disease
2008
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
cGMP-Dependent Protein Kinases and cGMP Phosphodiesterases in Nitric Oxide and cGMP Action
2010 Standout
Chronic sildenafil in men with diabetes and erectile dysfunction
2007
Integrating psychological and neurobiological considerations regarding the development and maintenance of specific Internet-use disorders: An Interaction of Person-Affect-Cognition-Execution (I-PACE) model
2016 Standout
In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid
2010 Standout
Testosterone treatment improves body composition and sexual function in men with COPD, in a 6-month randomized controlled trial
2004
Sexual dysfunction in men and women with endocrine disorders
2007
Dopamine and Oxytocin Interactions Underlying Behaviors: Potential Contributions to Behavioral Disorders
2010
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol
2006 Standout
Laparoscopic Radical Prostatectomy
2001
The impact of hormones on menopausal sexuality: a literature review
2004
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Androgen deficiency, diabetes, and the metabolic syndrome in men
2007
Nitrite-Derived Nitric Oxide Protects the Rat Kidney against Ischemia/Reperfusion Injury In Vivo
2007
Antioxidants: A Possible Role in Kidney Protection
2003
Lipid oxidation and improving the oxidative stability
2010 Standout
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Robotic radical prostatectomy: A technique to reduce pT2 positive margins
2004 StandoutNobel
Candida Infections of Medical Devices
2004 Standout
Impact of Nanotechnology on Drug Delivery
2009 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
The Management of Peyronie’s Disease: Evidence-based 2010 Guidelines
2010
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
American Cancer Society prostate cancer survivorship care guidelines
2014
Cancer Interception
2011 Nobel
The Prosthesis Salvage Operation: Immediate Replacement of the Infected Penile Prosthesis
1996
American Society of Clinical Oncology Recommendations on Fertility Preservation in Cancer Patients
2006 Standout
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Inhibition of the tonic contraction in the treatment of erectile dysfunction
2003
Prostate Specific Antigen Best Practice Statement: 2009 Update
2009
Prostate Cancer Diagnosis Among Men With Isolated High-Grade Intraepithelial Neoplasia Enrolled Onto a 3-Year Prospective Phase III Clinical Trial of Oral Toremifene
2013
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Urinary catheter policies for long-term bladder drainage
2012
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Pentraxin 3: A Novel Biomarker for Predicting Progression from Prostatic Inflammation to Prostate Cancer
2014
A tale of two trials: The impact of 5α-reductase inhibition on prostate cancer (Review)
2014
Cancer treatment and survivorship statistics, 2016
2016 Standout
Strategies for the removal of short-term indwelling urethral catheters in adults
2007
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Cancer treatment and survivorship statistics, 2019
2019 Standout
Prospective Randomized Study of Treatment of Large Proximal Ureteral Stones: Extracorporeal Shock Wave Lithotripsy Versus Ureterolithotripsy Versus Laparoscopy
2011
The Metabolic Syndrome
2008 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
The diagnostic accuracy and cost-effectiveness of magnetic resonance spectroscopy and enhanced magnetic resonance imaging techniques in aiding the localisation of prostate abnormalities for biopsy: a systematic review and economic evaluation
2013
Global cancer statistics, 2012
2015 Standout
Erectile Dysfunction in Diabetes Mellitus
2009
Peyronie’s Disease Intervention Trials: Methodological Challenges and Issues
2008
Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART II
2016 Standout
LONG-TERM EXPERIENCE WITH SALVAGE OF INFECTED PENILE IMPLANTS
2000
Diffusion-Weighted MRI in the Body: Applications and Challenges in Oncology
2007 Standout
Anatomy, Physiology, and Pathophysiology of Erectile Dysfunction
2010
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations
2015
Patterns of Repeat Prostate Biopsy in Contemporary Clinical Practice
2014
Cancer de la prostate
2007
The Management of Peyronie's Disease: Evidence-based 2010 Guidelines
2011
Works of Cláudio Telöken being referenced
Diabetes mellitus is associated with subnormal serum levels of free testosterone in men
2005
Successful birth after injection of frozen human oocytes with frozen epididymal spermatozoa
2005
Glycosylated haemoglobin levels and the severity of erectile function in diabetic men
2005
THERAPEUTIC EFFECTS OF HIGH DOSE YOHIMBINE HYDROCHLORIDE ON ORGANIC ERECTILE DYSFUNCTION
1998
Comparative cross‐over study of sildenafil and apomorphine for treating erectile dysfunction
2008
Intracavernosal etilefrine self-injection therapy for recurrent priapism: One decade of follow-up
2005
Effect of Dutasteride on the Risk of Prostate Cancer
2010
Is there any relation between serum levels of total testosterone and the severity of erectile dysfunction?
2002
Estudio prospectivo que compara laparoscopia y cirugía abierta para el tratamiento de cálculos ureterales impactados
2009
The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction
2002
Urethral catheter removal 7 or 14 days after radical retropubic prostatectomy: clinical implications and complications in a randomized study
2004
Prevalence of Peyronie's disease in men over 50-y-old from Southern Brazil
2001
Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra®) in the treatment of erectile dysfunction in Brazilian and Mexican men
2002
Protective effect of allopurinol in the renal ischemia–reperfusion in uninephrectomized rats
2000
EXPERIENCE WITH EARLY CATHETER REMOVAL AFTER RADICAL RETROPUBIC PROSTATECTOMY
2000
LOW SERUM TESTOSTERONE LEVELS ARE ASSOCIATED WITH POSITIVE SURGICAL MARGINS IN RADICAL RETROPUBIC PROSTATECTOMY: HYPOGONADISM REPRESENTS BAD PROGNOSIS IN PROSTATE CANCER
2005
Management of Erectile Dysfunction Secondary to Treatment for Localized Prostate Cancer
2001
INCIDENCE OF BIOPSY-DETECTABLE PROSTATE CANCER IN THE REDUCTION BY DUTASTERIDE OF PROSTATE CANCER EVENTS (REDUCE) TRIAL: BLINDED 2-YEAR RESULTS
2009
Prosthetic Penile Infection: “Rescue Procedure” with Rifamycin
1992
FURTHER ANALYSES FROM THE REDUCE PROSTATE CANCER RISK REDUCTION TRIAL
2009
TAMOXIFEN VERSUS PLACEBO IN THE TREATMENT OF PEYRONIE’S DISEASE
1999